ABOUT US

Experience:

Post-Doc, Max-Planck Institute of Biochemistry

Project Leader of DFG, Max-Planck Institute of Biochemistry

Principal lnvestigator, Tianjin lnstitute of lndustrial Biotechnology, Chinese Academy of Sciences

Leading Science & Technology Entrepreneur Talents Nanjing 321

Leading Entrepreneur Talents Suzhou Industrial Park

Education:

Nankai University, BS Biochemistry/MS Molecular biology

Georg-August-Universität/Max-Planck lnstitute of Biophysical Chemistry, Goettingen, Germany, Ph.D Neurobiology

Responsibilities:

Establishing a world-class R&D structure specializing in bioconjugates, integrating innovative science and cutting-edge technologies.

Leading the development of next generation first/best-in-class bioconjugate drug pipelines that significantly advance the current treatment landscape.

Leading technology innovation at GQ, focusing on unique iLDC/iGDC conjugation technologies, stable linker technologies, and novel payload development.

Experience:

Chief Scientific Officer (CSO) at Curon Biopharmaceutical, China

Vice President (VP) at Samsung Bioepis, Korea

Principal Research Scientist at Eli Lilly Research Laboratories, USA

Post-Doctoral Researcher at Tularik Inc. (Amgen SF), USA

Education:

Ph.D. in Biology from Purdue University, USA

Responsibilities:

Make the GQ’s clinical development strategy

Direct and oversee the design and implementation of all stage clinical projects

Prepare and direct overall clinical development plans

Design scientifically rigorous clinical development programs for the various indications

Monitor study progress, leading the analyses and data evaluation process for progress reporting and presentations to internal senior management team and external advisory and other relative groups

Prepare briefing and regulatory documents for regulatory agencies, such as BLAs, INDs, DSUR, and communicate with regulatory agencies about medical and other related issues

Planning and promotion of clinical professional activities

Experience:

Associate Chief Physician, Ruijin Hospital, Shanghai Jiaotong University School

Associate Chief Physician, associate professor, Chinese PLA General Hospital & Chinese PLA Medical School

Education:

Post-doctor, Dana-Farber Cancer Institute, USA

PhD., MD. in oncology, Chinese PLA General Hospital & Chinese PLA Medical School, China

MS, in pathology and pathophysiology, Chinese PLA General Hospital & Chinese PLA Medical School, China

BS, in Clinical medicine, Southern Medical University (The First Military Medical University of the PLA), China

Responsibilities:

Lead global regulatory submissions and develop regulatory and clinical strategies for all GQ pipeline products

Lead all aspects of cross-functional project management for drug development programs from preclinical to commercialization

Manage strategic alliances and external collaboration to maximize asset value of partnered programs

Experience:

Senior Vice President, GeneQuantum Healthcare

Vice President, Alphamab Oncology

Vice President, Luye Pharma

Global Regulatory Project Lead, GRA, Novartis

Senior Research Scientist, Pfizer Global Research & Development

Education:

Ph.D. Pharmaceutics, Rutgers University, USA (Graduate Advisor: Dr. Patrick J. Sinko)

M.S，Department of Biology, Nanjing University, China

B.S，Department for Intensive Instruction, Nanjing University, China

Responsibilities:

Responsible for establishing and optimizing GMP quality system

Responsible for CMC development and manufacturing to ensure the smooth progress of the projects

Experience:

Chief Technology Officer, Harbour BioMed, Suzhou/Shanghai , PR China

Senior VP，Innovent Biologics, Inc.. Suzhou, PR China

Education:

Ph.D., Bioanalytical Chemistry, Indiana University, Bloomington, IN